# Clinical Impact of Fast Phenotypic Antimicrobial Susceptibility Testing on Patients With Gram-Negative Rod Bacteremia

> **NCT03745014** · NA · WITHDRAWN · sponsor: **Accelerate Diagnostics, Inc.**

## Conditions studied

- Gram-negative Bacteremia

## Interventions

- **DIAGNOSTIC_TEST:** Accelerate Pheno
- **DIAGNOSTIC_TEST:** Standard of Care

## Key facts

- **NCT ID:** NCT03745014
- **Lead sponsor:** Accelerate Diagnostics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-09-30
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-08-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No sites identified with IRB approval
- **Last updated:** 2020-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03745014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03745014, "Clinical Impact of Fast Phenotypic Antimicrobial Susceptibility Testing on Patients With Gram-Negative Rod Bacteremia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03745014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*